What palliative care can do for motor neurone disease patients and their families

European Journal of Palliative Care

Volumn 20, Issue 6, 2013, Pages 286-289

  Oliver, David ^a   Aoun, Samar ^b  

^a UNIVERSITY OF KENT   (United Kingdom)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887853465     PISSN: 13522779     EISSN: 14790793     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Andersen PM, Abrahams S, Borasio GD et al. The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol 2012; 19: 360-375.
2. Bensimon G, Lacomblez L, Meininger V. ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Eng J Med 1994; 330: 585-591.
3. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007; 369: 2031-2041.
4. www.who.int/cancer/palliative/definition/en/ (last accessed 19/07/2013)
5. Borasio GD, Oliver D. Control of symptoms: other symptoms (including depression). In: Oliver D, Borasio GD, Walsh D (eds). Palliative Care in Amyotrophic Lateral Sclerosis-from Diagnosis to Bereavement, 2nd edn. Oxford: Oxford University Press, 2006.
6. Oliver D. The quality and care of symptom control-the effects on the terminal phase of ALS/MND. J Neurol Sci 1996; 139(suppl): 134-136.
7. Oliver D. Opioid medication in the palliative care of motor neurone disease. Palliat Med 1998; 12: 113-115.
8. Oliver DJ, Campbell C, O'Brien T et al. Medication in the last days of life for motor neurone disease/amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010; 11: 562-564.
9. Heffernan C, Jenkinson C, Holmes T et al. Nutritional management in MND/ALS patients: an evidence based review. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 72-83.
10. Miller RG, Jackson CE, Karsarkis EJ et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1218-1226.
11. Stone CA, O'Leary N. Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhoea in patients with amyotrophic lateral sclerosis. J Pain Symptom Manage 2009; 37: 246-258.
12. Heffernan C, Jenkinson C, Holmes T et al. Management of respiration in MND/ALS patients: an evidence based review. Amyotrophic Lateral Scler 2006; 7: 5-15.
13. National Institute for Health and Care Excellence. The use of non-invasive ventilation in the management of motor neurone disease. London: NICE, 2010. www.nice.org.uk/guidance/CG105 (last accessed 19/07/2013)
14. Bourke SC, Tomlinson M, Williams TL et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol 2006; 5: 140-147.
15. Gallagher D, Monroe B. Psychosocial care. In: Oliver D, Borasio GD, Walsh D (eds). Palliative Care in Amyotrophic Lateral Sclerosis-from Diagnosis to Bereavement, 2nd edn. Oxford: Oxford University Press, 2006.
16. Aoun SM, Bentley B, Funk L et al. A 10-year literature review of family caregiving for motor neurone disease: moving from caregiver burden studies to palliative care interventions. Palliat Med 2013; 27: 437-446.
17. Aoun SM, Connors SL, Priddis L, Breen LJ, Colyer S. Motor neurone disease family carers' experiences of caring, palliative care and bereavement: an exploratory qualitative study. Palliat Med 2012; 26: 842-850.
18. Lambert R. Spiritual care. In: Oliver D, Borasio GD, Walsh D (eds). Palliative Care in Amyotrophic Lateral Sclerosis-from Diagnosis to Bereavement, 2nd edn. Oxford: Oxford University Press, 2006.
19. Oliver D, Watson S. Multidisciplinary care. In: Oliver D (ed). End of Life Care in Neurological Disease. London: Springer, 2012.
20. Oliver D. Webb S. The involvement of specialist palliative care in the care of people with motor neurone disease. Palliat Med 2000; 14: 427-428.
21. Chiò A, Bottacchi E, Buffa C, Mutani R, Mora G; PARALS. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 2006; 77: 948-950.
22. Bede P, Hardiman O, O'Brannagain D. An integrated framework of early intervention palliative care in motor neurone disease as a model for progressive neurodegenerative diseases. 7th European ALS Congress, Turin, Italy, 2009.
23. National End of Life Care Programme. End of life care in long term neurological conditions: a framework for implementation. www.endoflifecare.nhs.uk/assets/ downloads/improving_eolc_neurology.pdf (last accessed 19/07/2013)
24. Oliver D, Borasio GD. Palliative care for patients with MND/ALS. European Journal of Palliative Care 2004; 11: 185-187.
25. O'Brien T, Kelly M, Saunders C. Motor neurone disease: a hospice perspective. BMJ 1992; 304: 471-473.
26. Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 2001; 248: 612-616.